Reports for TEVA-BUDESONIDE
Brand name
TEVA-BUDESONIDE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02465949 |
Ingredients
BUDESONIDE |
Ingredient Strength
0.125 MG |
ATC Code
R03BA |
ATC Descriptor
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-BUDESONIDE | 20 | Resolved | 2020-03-06 | 2020-03-19 | 107964 |
| TEVA-BUDESONIDE | 20pk | Resolved | 2021-06-03 | 2021-10-14 | 140390 |
| TEVA-BUDESONIDE | 2 | Resolved | 2022-08-18 | 2023-10-06 | 167197 |
| TEVA-BUDESONIDE | 2 | Resolved | 2023-06-20 | 2023-07-06 | 195815 |
| TEVA-BUDESONIDE | 2 pk | Resolved | 2023-11-03 | 2024-01-19 | 209145 |
| TEVA-BUDESONIDE | 20pk | Actual shortage | 2024-08-08 | 2025-03-13 | 234891 |
Showing 1 to 6 of 6
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0